Presentamos el caso de un varón de 73 años con antecedentes de hipertensión arterial, ingresado en UCI-A por neumonía bilateral por COVID-19. Presentaba anemización diaria a pesar de la transfusión de hemoderivados. Estaba en tratamiento con heparina de bajo peso molecular a dosis anticoagulantes. En la TC abominopélvica se objetivó un aumento de tamaño y heterogeneidad de la densidad del psoas ilíaco izquierdo en relación con hematoma, así como otro de menor tamaño en el psoas contralateral.
Hematoma del músculo psoas bilateral por infección SARS-CoV-2 en paciente crítico
Bilateral psoas muscle hematoma in critical patient COVID-19
Elena Simón Polo
Luisa María Charco Roca
Jose María Jiménez Vizuete
Autor para correspondencia.
Issue date 2022 Jun.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

